Hormonal
Berberine administration (0.2–10 g/day) significantly reduces oxidative stress and inflammation in Type 2 Diabetes Mellitus (T2DM) patients and animal models, leading to improved insulin sensitivity and glycemic control comparable to metformin.
If you have Type 2 Diabetes, berberine is a botanical supplement shown to lower blood glucose by 20-40%, performing similarly to standard drugs like metformin. It works by reducing inflammation and oxidative stress, which improves insulin sensitivity. Clinical studies used doses between 0.2g and 1g daily. It may be particularly useful for patients who also have liver issues, as berberine appears to protect hepatic function while lowering sugar.
Berberine is a biologically active botanical that can combat oxidative stress and inflammation and thus ameliorate DM, especially type 2 DM... The treatment efficacy of berberine has been found comparable with the reference antidiabetic drugs such as metformin... Various clinical studies have described the safety and effectiveness of berberine (at a dose of 0.2–10 g/day) in treating T2DM patients. Generally, a decrease in blood glucose level by 20–40% is reported in fasting patients treated with berberine alone, this effect resembles to that of rosiglitazone and metformin
Why this rating
The paper is a review citing multiple animal and some human studies, but notes the need for large-scale, high-quality, long-term randomized clinical trials.
Source
The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine
Xueling Ma et al. · Frontiers in Pharmacology · 2018
DOI 10.3389/fphar.2018.00782
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →